Wells Fargo Upgrades BioMed Realty Trust (BMR) to Outperform; Upside Potential, Downside Limited
Tweet Send to a Friend
Wells Fargo upgrades BioMed Realty Trust (NYSE: BMR) to Outperform. Valuation range increased to $18-$20/sh from $16-$18.
Wells analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
